Supplementary Figure 1.docx (44.88 kB)

Supplementary Figure 1. Burden of Illness & Outcomes in 2nd Line Large B-Cell Lymphoma Treatment: Real-world Analysis of Medicare Beneficiaries

figure

posted on 2021-10-20, 08:18 authored by Karl M. Kilgore, Iman Mohammadi, Anny C. Wong, Julia Thornton Snider, Paul Cheng, Amy Schroeder, Anik R. Patel

Supplementary Figure 1. Overall Survival, Relative to Start of 2nd LOT, ASCT-Intended, Stratified by Time-to-Relapse

Funding

Kite, A Gilead Company, Santa Monica, CA

History

Usage metrics

Keywords

Economic burden Medicare large B-cell lymphoma line of therapy stem-cell transplant treatment patterns Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

Licence

CC BY-NC-ND 4.0